Frontier Biotechnologies (SHSE:688221) 3-Year EBITDA Growth Rate : -2.70% (As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Frontier Biotechnologies 3-Year EBITDA Growth Rate?

Frontier Biotechnologies's EBITDA per Share for the three months ended in Sep. 2024 was ¥-0.08.

During the past 3 years, the average EBITDA Per Share Growth Rate was -2.70% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 0.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 10 years, the highest 3-Year average EBITDA Per Share Growth Rate of Frontier Biotechnologies was 12.90% per year. The lowest was -165.90% per year. And the median was -23.70% per year.

Competitive Comparison of Frontier Biotechnologies's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Frontier Biotechnologies's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Frontier Biotechnologies's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Frontier Biotechnologies's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Frontier Biotechnologies's 3-Year EBITDA Growth Rate falls into.

Save Embed

;

Save Embed

;

Frontier Biotechnologies 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Frontier Biotechnologies (SHSE:688221) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Frontier Biotechnologies 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Frontier Biotechnologies's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Frontier Biotechnologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Frontier Biotechnologies Inc (SHSE:688221) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

No. 5 Gande Road, 7th Floor, Science Park, Jiangning District, Jiangsu Province, Nanjing, CHN, 211122

Website

http://www.frontierbiotech.com

Frontier Biotechnologies Inc is an innovative biomedical company. It is engaged in the production and sales of innovative drugs for major unmet clinical needs. The company focuses on the research and development of new drugs in the field of long-acting peptides and differentiated product development strategies for unmet clinical and patient needs.

Frontier Biotechnologies Headlines

No Headlines